文献速递免疫规划传染病防控与疫情报告

金黄色葡萄球菌分泌蛋白EapH1/EapH2疫苗接种对定植与侵袭性疾病的影响

Vaccination with the Staphylococcus aureus secreted proteins EapH1 and EapH2 impacts both S. aureus carriage and invasive disease.
PubMed 文献 · Vaccine · 2018-11-28

该研究在小鼠模型中评估表达金黄色葡萄球菌分泌蛋白EapH1和EapH2的腺病毒5型与改良安卡拉痘苗病毒载体疫苗。肌内接种显著减少肾脏脓肿模型中的细菌载量但效应幅度小,单次鼻内接种减少胃肠道定植,提示该疫苗可能提供不依赖抗生素的定植减少与侵袭性疾病保护。

要点

  • 肌内接种EapH1/EapH2载体疫苗显著减少小鼠肾脏脓肿模型细菌载量但幅度小
  • 单次鼻内接种表达EapH1/EapH2的腺病毒疫苗减少金黄色葡萄球菌胃肠道定植
  • 该疫苗策略可能提供不依赖抗生素的定植减少与侵袭性疾病保护

核心结论

  • 针对EapH1/EapH2蛋白的疫苗接种可能提供不依赖抗生素的减少金黄色葡萄球菌定植的途径,并有助于预防侵袭性疾病。

研究设计与样本

  • 小鼠经肌内或鼻内接种表达EapH1和EapH2蛋白的腺病毒5型与改良安卡拉痘苗病毒载体疫苗或对照病毒。
  • 采用小鼠金黄色葡萄球菌定植模型连续采集粪便监测定植,静脉攻击后通过肾脏细菌载量和脓肿数量监测侵袭性疾病。

主要发现

  • 肌内接种表达EapH1和EapH2的腺病毒5型与改良安卡拉痘苗病毒载体疫苗显著减少小鼠肾脏脓肿模型中的细菌回收,但效应幅度小。
  • 单次鼻内接种表达这些蛋白的腺病毒疫苗减少金黄色葡萄球菌胃肠道定植。

临床怎么用

  • 目前证据仅来自小鼠模型,尚不能直接转化为临床接种建议。
  • 提示EapH1/EapH2可作为抗生素非依赖的定植减少与侵袭性疾病保护的候选疫苗靶点。

局限性

  • 研究仅在小鼠模型中进行,人体有效性与安全性未评估。
  • 肌内接种减少肾脏细菌载量的效应幅度小。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: There is a need for an efficacious vaccine reducing infections due to Staphylococcus aureus, a common cause of community and hospital infection. Infecting organisms originate from S. aureus populations colonising the nares and bowel. Antimicrobials are widely used to transiently reduce S. aureus colonisation prior to surgery, a practice which is selecting for resistant S. aureus isolates. S. aureus secretes multiple proteins, including the protease inhibitors extracellular adhesion protein homologue 1 and 2 (EapH1 and EapH2). METHODS: Mice were vaccinated intramuscularly or intranasally with Adenovirus serotype 5 and Modified Vaccinia Ankara viral vectors expressing EapH1 and EapH2 proteins, or with control viruses. Using murine S. aureus colonisation models, we monitored S. aureus colonisation by sequential stool sampling. Monitoring of S. aureus invasive disease after intravenous challenge was performed using bacterial load and abscess numbers in the kidney. RESULTS: Intramuscular vaccination with Adenovirus serotype 5 and Modified Vaccinia Ankara viral vectors expressing EapH1 and EapH2 proteins significantly reduces bacterial recovery in the murine renal abscess model of infection, but the magnitude of the effect is small. A single intranasal vaccination with an adenoviral vaccine expressing these proteins reduced S. aureus gastrointestinal (GI) tract colonisation. CONCLUSION: Vaccination against EapH1 / EapH2 proteins may offer an antibiotic independent way to reduce S. aureus colonisation, as well as contributing to protection against S. aureus invasive disease.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Elshina E, Allen ER, Flaxman A, et al. Vaccination with the Staphylococcus aureus secreted proteins EapH1 and EapH2 impacts both S. aureus carriage and invasive disease. Vaccine. 2018. PMID: 30502067. doi:10.1016/j.vaccine.2018.11.036

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。